systemic lupus erythematosus
Conditions
Interventions
Dose of glucocorticoids. Rapid tapering group After continuing the initial dose for 2 to 4 weeks, weigh down every 1 week according to the following dose 60 mg, 50 mg, 45 mg, 40 mg, 35 mg, 30 mg,
Sponsors
Juntendo University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients over 20 years old 2) Patients who got consent in writing 3) Patients who met SLE classification criteria or SLICC classification criteria of the American College of Rheumatology 1997 and were diagnosed with SLE in 1997 4) In principle, a combination of immunosuppressive drugs receiving medicine of corticosteroid at a dose of 0.5 mg / kg / day or more and 40 mg / day in terms of prednisolone is used but patients with or without interruption due to side effects etc.
Exclusion criteria
Exclusion criteria: 1) Persons who did not obtain consent 2) Patients with poorly controlled complications 3) Pregnant or lactating women 4) Male and female with pregnancy plan within 52 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relapse free survival rate at week 52. | — |
Countries
Japan
Contacts
Public ContactYoshiyuki Abe
Juntendo University Department of Internal Medicine and Rheumatology
Outcome results
None listed